New Genetic Test Targets Rare X-Linked Movement Disorder
MDSpire News
November 15, 2025
You now have access to the trusted editorial news and specialty content you've known from the Conexiant news site—all within the MDSpire experience.
Learn more

A targeted genetic test for X-linked dystonia-parkinsonism (XDP) has been developed by scientists at Brigham and Women’s Hospital and Harvard Medical School.
The test focuses on specific DNA changes in the TAF1 gene, which are difficult to detect with standard sequencing methods.
XDP primarily affects men of Filipino ancestry and causes symptoms like muscle spasms, tremors, and abnormal postures.
The assay correctly identified all positive cases in validation, including two patients previously diagnosed as negative.
Increased awareness and targeted testing may improve early diagnosis for patients with Filipino ancestry.
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.
Affiliations:
Specialties:
Areas of Expertise: